| PRECLINICAL | evidence | Di-(2-ethylhexyl) phthalate-induced tumor growth is regulated by primary cilium formation via the axis of H(2)O(2) production-thymosin beta-4 gene expression. | TB4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Thymosin beta-4 prenatal administration improves fetal development and halts side effects due to preterm delivery. | TB4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection. | Tbeta4 | Inflammation | 2021-01-01 |
| PRECLINICAL | evidence | TMSB4 Overexpression Enhances the Potency of Marrow Mesenchymal Stromal Cells for Myocardial Repair. | Tbeta4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Multisample Mass Spectrometry-Based Approach for Discovering Injury Markers in Chronic Kidney Disease. | Thymosin beta 4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Acupuncture Regulates Serum Differentially Expressed Proteins in Patients with Chronic Atrophic Gastritis: A Quantitative iTRAQ Proteomics Study. | Thymosin beta 4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction. | TB4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Commentary: Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms. | Thymosin beta 4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Di-(2-ethylhexyl) phthalate-induced tumor growth is regulated by primary cilium formation via the axis of H(2)O(2) production-thymosin beta-4 gene expression. | Thymosin beta 4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction. | Thymosin beta 4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Solid-State, Thermal Synthesis of Peptide/Protein-Boron Cluster Conjugates. | Tbeta4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Progress on the Function and Application of Thymosin beta4. | Tbeta4 | Inflammation | 2021-01-01 |
| PRECLINICAL | evidence | Purinergic Signaling Involvement in Thymosin beta4-mediated Corneal Epithelial Cell Migration. | Tbeta4 | Eye & vision health · preclinical | 2020-11-01 |
| PRECLINICAL | evidence | The LINC00961 transcript and its encoded micropeptide, small regulatory polypeptide of amino acid response, regulate endothelial cell function. | Tbeta4 | — | 2020-10-01 |
| PRECLINICAL | evidence | Thymosin‑beta 4 induces angiogenesis in critical limb ischemia mice via regulating Notch/NF‑kappaB pathway. | Tbeta4 | Inflammation | 2020-10-01 |
| PRECLINICAL | evidence | Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in Pseudomonas aeruginosa Induced Keratitis. | Tbeta4 | Eye & vision health | 2020-09-18 |
| PRECLINICAL | evidence | Top down proteomic analysis of gingival crevicular fluid in deciduous, exfoliating and permanent teeth in children. | Thymosin β4 | — | 2020-08-30 |
| PRECLINICAL | evidence | Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis. | Thymosin β4 | — | 2020-08-07 |
| PRECLINICAL | evidence | Serum profile of low molecular weight fucosylated glycoproteins for early diagnosis of hepatocellular carcinoma. | Thymosin beta 4 | — | 2020-08-01 |
| PRECLINICAL | evidence | Molecular Motions and Interactions in Aqueous Solutions of Thymosin-beta(4) , Stabilin CTD and Their 1 : 1 Complex, Studied by (1) H-NMR Spectroscopy. | Tbeta4 | — | 2020-07-02 |
| PRECLINICAL | evidence | Anti-inflammatory effects of glycine thymosin beta4 eye drops in experimental dry eye. | Tbeta4 | — | 2020-06-01 |
| PRECLINICAL | evidence | Corrigendum: Molecular Motions and Interactions in Aqueous Solutions of Thymosin-beta(4) , Stabilin C-Terminal Domain (CTD) and Their 1:1 Complex Studied by (1) H NMR Spectroscopy. | Thymosin beta 4 | — | 2020-05-05 |
| PRECLINICAL | evidence | 5-HT(1A)R alleviates Abeta-induced cognitive decline and neuroinflammation through crosstalk with NF-kappaB pathway in mice. | Tbeta4 | — | 2020-05-01 |
| PRECLINICAL | evidence | Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4. | Tbeta4 | — | 2020-04-12 |
| PRECLINICAL | evidence | Dimeric Thymosin beta4 Loaded Nanofibrous Interface Enhanced Regeneration of Muscular Artery in Aging Body through Modulating Perivascular Adipose Stem Cell-Macrophage Interaction. | Tbeta4 | — | 2020-04-01 |
| PRECLINICAL | evidence | A new insight into thymosin beta4, a promising therapeutic approach for neurodegenerative disorders. | Tbeta4 | Inflammation | 2020-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 Identified by Transcriptomic Analysis from HF Anagen to Telogen Promotes Proliferation of SHF-DPCs in Albas Cashmere Goat. | Tbeta4 | — | 2020-03-25 |
| PRECLINICAL | evidence | Thymosin beta4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study. | Tbeta4 | — | 2020-03-24 |
| PRECLINICAL | evidence | Thymosin beta4-Enhancing Therapeutic Efficacy of Human Adipose-Derived Stem Cells in Mouse Ischemic Hindlimb Model. | Tbeta4 | Wound healing | 2020-03-21 |
| PRECLINICAL | evidence | Ependymoma Pediatric Brain Tumor Protein Fingerprinting by Integrated Mass Spectrometry Platforms: A Pilot Investigation. | Thymosin beta 4 | — | 2020-03-13 |
| PRECLINICAL | evidence | Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers. | Thymosin β4 | preclinical | 2020-03-10 |
| PRECLINICAL | evidence | Thymosin beta 4 attenuates PrP(106-126)-induced human brain endothelial cells dysfunction. | Tbeta4 | preclinical | 2020-02-15 |
| PRECLINICAL | evidence | N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Mitigates Experimental Colitis Through Inhibition of Intestinal Mucosal Inflammatory Responses via MEK-ERK Signaling. | Tbeta4 | — | 2020-01-01 |
| PRECLINICAL | evidence | Thymosin beta4: A Multi-Faceted Tissue Repair Stimulating Protein in Heart Injury. | Tbeta4 | — | 2020-01-01 |
| PRECLINICAL | evidence | Electrospun thymosin Beta-4 loaded PLGA/PLA nanofiber/ microfiber hybrid yarns for tendon tissue engineering application. | Tbeta4 | preclinical | 2020-01-01 |
| PRECLINICAL | evidence | The Overexpression of Tbeta4 in the Hair Follicle Tissue of Alpas Cashmere Goats Increases Cashmere Yield and Promotes Hair Follicle Development. | Tbeta4 | — | 2019-12-31 |
| PRECLINICAL | evidence | Metallacarboranes as a tool for enhancing the activity of therapeutic peptides. | Tbeta4 | Skin appearance & aging · preclinical | 2019-12-01 |
| PRECLINICAL | evidence | Thymosin beta4 promotes autophagy and repair via HIF-1alpha stabilization in chronic granulomatous disease. | Tbeta4 | Longevity & cellular aging | 2019-12-01 |
| PRECLINICAL | evidence | A disease-associated mutation in fibrillin-1 differentially regulates integrin-mediated cell adhesion. | TB4 | — | 2019-11-29 |
| PRECLINICAL | evidence | Integrative Analysis of Methylation and Transcriptional Profiles to Reveal the Genetic Stability of Cashmere Traits in the Tbeta4 Overexpression of Cashmere Goats. | Tbeta4 | — | 2019-11-20 |
| PRECLINICAL | evidence | miR-200a mediates protection of thymosin beta-4 in cardiac microvascular endothelial cells as a novel mechanism under hypoxia-reoxygenation injury. | Tbeta4 | — | 2019-11-01 |
| PRECLINICAL | evidence | Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved. | Thymosin β4 | — | 2019-11-01 |
| PRECLINICAL | evidence | Inhibition of microRNA-34a mediates protection of thymosin beta 4 in endothelial progenitor cells against advanced glycation endproducts by targeting B-cell lymphoma 2. | Thymosin beta 4 | preclinical | 2019-10-01 |
| PRECLINICAL | evidence | Thymosin beta4: potential to treat epidermolysis bullosa and other severe dermal injuries. | Thymosin beta 4 | — | 2019-10-01 |
| PRECLINICAL | evidence | Thymosin beta 4 attenuates oxidative stress-induced injury of spinal cord-derived neural stem/progenitor cells through the TLR4/MyD88 pathway. | Tbeta4 | — | 2019-07-30 |
| PRECLINICAL | evidence | Chivosazole A Modulates Protein-Protein Interactions of Actin. | Thymosin β4 | — | 2019-07-26 |
| PRECLINICAL | evidence | Thymosin beta 4-Induced Autophagy Increases Cholinergic Signaling in PrP (106-126)-Treated HT22 Cells. | Tbeta4 | Longevity & cellular aging | 2019-07-01 |
| PRECLINICAL | evidence | Tbeta4-Ac-SDKP pathway: Any relevance for the cardiovascular system? | Tbeta4 | Lipid & cardiovascular markers | 2019-07-01 |
| PRECLINICAL | evidence | Comparative proteomic analysis of plasma of children with congenital heart disease. | Tbeta4 | — | 2019-07-01 |
| PRECLINICAL | evidence | Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy. | Thymosin beta 4 | Kidney function | 2019-06-01 |